These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 7811053

  • 1. N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.
    Goldstein FW, Kitzis MD, Acar JF.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2218-20. PubMed ID: 7811053
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
    Testa RT, Petersen PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
    [Abstract] [Full Text] [Related]

  • 3. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
    [Abstract] [Full Text] [Related]

  • 4. Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.
    Johnson DM, Jones RN.
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):53-7. PubMed ID: 8988765
    [Abstract] [Full Text] [Related]

  • 5. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.
    Brown BA, Wallace RJ, Onyi G.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):874-8. PubMed ID: 8849243
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
    Petersen PJ, Jacobus NV, Weiss WJ, Sum PE, Testa RT.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
    [Abstract] [Full Text] [Related]

  • 7. In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2513-5. PubMed ID: 7840601
    [Abstract] [Full Text] [Related]

  • 8. Susceptibilities of Neisseria gonorrhoeae to the glycylcyclines.
    Whittington WL, Roberts MC, Hale J, Holmes KK.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1864-5. PubMed ID: 7486935
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of two glycylcyclines.
    Wise R, Andrews JM.
    Antimicrob Agents Chemother; 1994 May; 38(5):1096-102. PubMed ID: 8067744
    [Abstract] [Full Text] [Related]

  • 10. Recent developments in tetracycline antibiotics.
    Sum PE, Sum FW, Projan SJ.
    Curr Pharm Des; 1998 Apr; 4(2):119-32. PubMed ID: 10197036
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines.
    Weiss WJ, Jacobus NV, Petersen PJ, Testa RT.
    J Antimicrob Chemother; 1995 Jul; 36(1):225-30. PubMed ID: 8537270
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America.
    Gales AC, Jones RN, Andrade SS, Pereira AS, Sader HS.
    Braz J Infect Dis; 2005 Oct; 9(5):348-56. PubMed ID: 16410885
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of two glycylcyclines against gram-positive bacteria.
    Eliopoulos GM, Wennersten CB, Cole G, Moellering RC.
    Antimicrob Agents Chemother; 1994 Mar; 38(3):534-41. PubMed ID: 8203851
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936.
    Sum PE, Petersen P.
    Bioorg Med Chem Lett; 1999 May 17; 9(10):1459-62. PubMed ID: 10360756
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria.
    Nord CE, Lindmark A, Persson I.
    Eur J Clin Microbiol Infect Dis; 1993 Oct 17; 12(10):784-6. PubMed ID: 7802861
    [Abstract] [Full Text] [Related]

  • 16. A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter.
    Someya Y, Yamaguchi A, Sawai T.
    Antimicrob Agents Chemother; 1995 Jan 17; 39(1):247-9. PubMed ID: 7695316
    [Abstract] [Full Text] [Related]

  • 17. Activity of glycylcyclines CL 329998 and CL 331002 against minocycline-resistant and other strains of methicillin-resistant Staphylococcus aureus.
    Hamilton-Miller JM, Shah S.
    J Antimicrob Chemother; 1996 Jun 17; 37(6):1171-5. PubMed ID: 8836820
    [Abstract] [Full Text] [Related]

  • 18. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases.
    Biedenbach DJ, Beach ML, Jones RN.
    Diagn Microbiol Infect Dis; 2001 Aug 17; 40(4):173-7. PubMed ID: 11576790
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates.
    Gales AC, Jones RN.
    Diagn Microbiol Infect Dis; 2000 Jan 17; 36(1):19-36. PubMed ID: 10744364
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S, Lupo A, Mezzatesta ML, Campanile F, Santagati M, Stefani S.
    Int J Antimicrob Agents; 2008 Mar 17; 31(3):209-15. PubMed ID: 17646087
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.